Trial Profile
VINORELBINE CAPECITABINE EPIRUBICINE AS FIRST LINE THERAPY IN ADVANCED BREAST CANCER PATIENTS.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 May 2011
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary) ; Capecitabine; Epirubicin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 17 May 2011 New trial record